Free Trial

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 1 of 15

 
 

Fresenius Medical Care (NYSE:FMS)

Consensus Rating
Hold
Rating Score
2.0
Ratings Breakdown
1 Buy Ratings, 2 Hold Ratings, 1 Sell Ratings.
Consensus Price Target
$22.00 (6.2% Upside)

About Fresenius Medical Care

Fresenius Medical Care logoFresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
7/31/2024Truist FinancialLower Price TargetHold ➝ Hold$24.00 ➝ $22.00
5/15/2024Truist FinancialBoost Price TargetHold ➝ Hold$21.00 ➝ $24.00
1/8/2024Morgan StanleyDowngradeEqual Weight ➝ Underweight
11/24/2023HSBCUpgradeReduce ➝ Hold
11/17/2023Societe GeneraleUpgradeHold ➝ Buy
10/11/2023Truist FinancialLower Price TargetHold ➝ Hold$28.00 ➝ $24.00
9/13/2023UBS GroupUpgradeSell ➝ Neutral
8/16/2023Morgan StanleyBoost Price Target€40.50
8/14/2023UBS GroupDowngradeBuy ➝ Neutral
8/1/2023CitigroupInitiated CoverageNeutral
 

“I’ll Give You the Knowledge and Confidence You Need to Make Your First Options Trade in Five Days or Less… Guaranteed!” (Ad)

Starting Monday, September 23 — a veteran 25-year Chicago Options Exchange market-maker will show you his UOA options secret that could help you consistently target gains of 126%… 245%… even 463% or more… Often in 30 days or less… No matter what the market is doing right now.

Go here for the full details now.